Clinical Trials Browser

Phase 3 × Completed × Carcinoma, Ductal, Breast × Clear all

NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Phase 3 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

NCT00433589 2022-11-17

MINDACT

Phase 3 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT01583426 2020-08-06

GeparSepto

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00004205 2017-12-12

BIG 1-98

Phase 3 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02125344 2017-07-13

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00044291 2015-07-31

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Phase 3 Completed

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00002967 2013-06-21

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Phase 3 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01508546 2012-01-12

Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer

Phase 3 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast